Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: TEXAS BIOMEDICAL RESEARCH INSTITUTE
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-09-27 to 2024-09-29
Current total value of award: $193026.34
Description: OBTAIN BABOONS FOR AN OMV-PERTUSSIS VACCINE STUDY TO BE CONDUCTED AT FDA/CBER FACILITY IN SILVER SPRING, MARYLAND.